JG
EVH icon

Jefferies Group’s Evolent Health EVH Stock Holding History

Jefferies Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35,000
Closed -$1.08M – 1734
2021
Q3 		$1.08M Buy
+35,000
New +$840K 0.01% 961

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Jefferies Group's EVH Position: Q3 2022 in Review

Jefferies Group reduced its Evolent Health (EVH) stake by 61% in Q3 2022, selling an estimated $114K and leaving 2,076 shares worth $74.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Jefferies Group first reported a position in EVH in Q2 2018 and has held it in 6 quarters since. The position peaked at $358K in Q2 2018. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

  • Jefferies Group held 2,076 shares of Evolent Health worth $74.6K as of Q3 2022.
  • Jefferies Group sold 3,247 Evolent Health shares in Q3 2022, an estimated $114K.
  • Evolent Health made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1489 holding.
  • Jefferies Group first reported a position in Evolent Health in Q2 2018 and has held it in 6 quarters since.
  • Jefferies Group's Evolent Health position peaked at $358K in Q2 2018.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.